Core Modifications of GSK3335103 toward Orally Bioavailable αvβ6 Inhibitors with Improved Synthetic Tractability
已完结20由 LZI 发布于 2025/9/22 12:28:53
DOI:10.1021/acs.jmedchem.4c02051
作者:Heather F. Hryczanek, John Barrett, Tim N. Barrett, Glenn A. Burley, Rosa E. Cookson, Richard J. D. Hatley, Nicholas D. Measom, James A. Roper, James E. Rowedder, Robert J. Slack, Connor B. ?mieja, Si
文献类型:期刊论文
补充材料:只需要正文